EU High Court Says Law Allows Royalties For Invalid Patents
Law360, New York (July 7, 2016, 6:50 PM EDT) -- The European Union’s highest court has endorsed the legality of a patent license agreement underlying Sanofi-Aventis’ €108 million ($119 million) arbitration award against Genentech, ruling Thursday that patent licensees must pay the agreed-upon royalty, even if the patent is revoked or not infringed.
The European Court of Justice advised a French court handling a dispute between Sanofi-Aventis Deutschland GmbH and Genentech Inc. that the bloc’s competition laws do not preclude payment of royalties on a patent licensing agreement after the invalidation of the patent, as long as the licensee was free to terminate the contract.
Similarly, the law doesn’t prohibit a...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!
Kirkland & Ellis LLP has redefined what it means to be the biggest of BigLaw — weighing in at 2,116 attorneys by year end 2018 and becoming the first firm since Law360 began tracking law firm head counts to top 2,000 U.S.-based attorneys.